FDA Enforcement Heating Up
On Oct. 28, 2009, the government announced a criminal indictment against Stryker Biotech and four current or past executives.
The indictment, filed in federal court in Massachusetts, alleges that the company and the named executives promoted an unapproved combination of two orthopedic products used as bone fillers.
Each product had been...
To view the full article, register now.